Author:
Lasaridis A.,Davies D. L.,Beretta-Piccoli C.,Brown J. J.,Fraser R.,Holloway C.,Ingram M.,Lever A. F.,Robertson J. I. S.,Semple P. F.
Publisher
Springer Berlin Heidelberg
Reference31 articles.
1. Schalekamp MADH, Wenting GJ, Man in T’Veld AJ (1981) Pathogenesis of mineralocorticoid hypertension. Clinics in Endocrinology and Metabolism 10: 397–418
2. Ferriss JB, Brown JJ, Fräser R, Lever AF, Robertson JIS (1981) Primary hyperaldosteronism. Clin Endocrinol Metab 10: 419–452
3. Davies DL, Beever DG, Brown JJ, Gumming AMM, Fräser R, Lever AF, Mason PA, Morton JJ, Robertson JIS, Titterington M, Tree M (1979) Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition? J Endocrinol 81: 79P–91 P
4. Liddle GW (1962) Discussion of ‘Secondary aldosteronism and reduced plasma renin in hypertensive disease’. Trans Assoc Am Physicians 80: 182
5. Baer L, Brunner HR, Buhler F, Laragh JH (1972) Pseudo-primary aldosteronism, a variant of low renin essential hypertension. In: Genest J, Koiw E (eds) Hypertension-1972. Springer, Berlin pp 459–472